From: Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China
IPE, N = 88
SPE, N = 92
P-value
Affected
38 (43.2)
42 (45.6)
0.640
 Delayed
16 (18.2)
4 (4.7)
0.003*
 Dosage decreased
1 (1.1)
0.740
 Stopped
13 (14.8)
25 (27.2)
0.042*
 Changed
9 (10.2)
12 (13.0)
0.556